Table 2.
Treatment | PFS | p value | OS | p value |
---|---|---|---|---|
Sorafenib | 5.5 | <0.0001 | 17.8 | 0.029 |
Placebo | 2.8 | 14.3 |
OS, overall survival; PFS, progression-free survival.
Treatment | PFS | p value | OS | p value |
---|---|---|---|---|
Sorafenib | 5.5 | <0.0001 | 17.8 | 0.029 |
Placebo | 2.8 | 14.3 |
OS, overall survival; PFS, progression-free survival.